Drug intelligence / Profile preview

Canker Cure

Development stage: Unknown
Lead developer: Innovative Concepts in Pharmaceutical Research
Modality: Small Molecules
Administration: Oral

Overview

Canker Cure is an oral dietary supplement formulated as a micronutrient complex designed to treat and prevent oral canker sores (aphthous ulcers). Developed by Innovative Concepts in Pharmaceutical Research, the product is intended to support the natural healing processes of the mouth lining. Unlike topical gels or rinses that provide temporary symptomatic relief, Canker Cure is a systemic treatment that provides essential nutrients to help the oral mucosa repair itself and resist future ulcerations. It is marketed as a consumer health product rather than a prescription pharmaceutical and is sold directly to consumers.

Brand names: Canker Cure
Other names: micronutrient supplementmouth ulcer pill

Beyond the preview

Go deeper on Canker Cure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canker Cure.

Explore the full profile